Evidence map›Paper›PMID 37664402›Full record

ReviewCureus2023

Heartache in a Bottle: Understanding Alcoholic Cardiomyopathy.

Nkechinyere L Ihekire, Okelue E Okobi, Enoobong Aderonke Adedoye, Patience F Akahara, Anita O Onyekwere, Jeffrey Afrifa-Yamoah, Falilatu B Akinyemi

Open access · diamondAbstract readReview
In one paragraph

Review in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 5 countries.

Nkechinyere L IhekireInternal Medicine, Windsor University School of Medicine, Cayon, KNA.
Okelue E OkobiFamily Medicine, Medficient Health Systems, Laurel, USA.
Enoobong Aderonke AdedoyeInternal Medicine, Mater Dei Hospital, Msida, MLT.
Patience F AkaharaFamily Medicine, Inglewood Medical Centre, Edmonton, CAN.
Anita O OnyekwereSchool of Medicine, Richmond Gabriel University, Kingstown, VCT.
Jeffrey Afrifa-YamoahInternal Medicine, Korle Bu Teaching Hospital, Accra, GHA.
Falilatu B AkinyemiInternal Medicine, Windsor University School of Medicine, Cayon, KNA.
Mater Dei Hospital · MTCanon (Japan) · JPKorle Bu Teaching Hospital · GHUniversity of Richmond · USVirtua Health · USWindsor University School of Medicine · KN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alcoholic cardiomyopathy (ACM) is a cardiac ailment marked by impaired contraction and dilation of one or both ventricles of the heart. The extent of daily alcohol intake and duration of alcohol abuse are linked to the development of ACM, although the exact thresholds and timeline for alcohol misuse to induce heart dysfunction remain uncertain. Thus, the objective of this systematic review is to comprehensively evaluate the existing knowledge on the specific disease entity, particularly in light of the ongoing issue of alcohol misuse, with the intention of determining if recent advancements and discoveries have significantly altered the understanding of this condition compared to the past century. This systematic review involved a literature search that was conducted on PubMed to identify suitable and appropriate literature for the study. The inclusion criteria encompassed articles that focused on ACM or the relationship between alcohol abuse and cardiac dysfunction, involved human subjects or relevant animal models, were written in the English language, and were published within the last 10 years. The exclusion criteria included duplicates, case reports, letters, editorials, and reviews not specifically addressing ACM. As a result, a total of 18 articles were included in this systematic review. The risk of bias was assessed through the use of the Cochrane risk-of-bias tool for clinical trials. The findings of this systematic review indicated that the likelihood of ACM occurrence significantly rose when the consumption of over 80 g of alcohol per day occurred for at least five years. The systematic review further revealed that ACM is associated with various detrimental changes in the cellular, structural, and histological aspects of the heart muscles, even though the specific clinical and histological characteristics of ACM have yet to be established. In individuals with an extensive history of excessive alcohol abuse, the diagnosis of ACM was reached through the exclusion of other potential causes of the condition. The fundamental approach to treatment lies in abstaining from alcohol. It is crucial to manage symptoms in individuals with secondary heart failure and address any related complications.

Indexed as

alcoholalcoholic cardiomyopathy (acm)alcoholic heart diseasealcohol-induced cardiomyopathydilated cardiomyopathy (dcm)

Identifiers

PMID37664402
PMCPMC10474910
OpenAlexW4385553394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.